Literature DB >> 2373575

Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists.

S Flinn1, J Gregory, L R McNaughton, S Tristram, P Davies.   

Abstract

Nine male recreational cyclist served as subjects in this experiment which included a control, placebo and caffeine trial. The aim of the experiment was to determine whether a 10 mg.kg-1 dose of caffeine given three hours prior to an incremental cycle ergometer exercise test, for caffeine naive subjects, would increase the time to exhaustion and therefore increase the amount of work undertaken by the cyclists. The cyclists initially worked at 100 watts for three minutes and then increased the workload by 50 watts every three minutes until exhaustion. Blood was drawn at the beginning of the test and every three minutes from an ante-cubital vein and was analysed for blood lactate, glucose and free fatty acids (FFA). Respiratory analysis was also undertaken and heart rate was monitored throughout the test. Subjects in the caffeine trial worked significantly longer and performed more work (p less than 0.05) than they did in either the control or placebo trials. FFA's were also significantly higher in this trial (p less than 0.05) and the lactate threshold was moved to the right as a percentage of the VO2max, which suggests less acidity and a decreased bicarbonate flushing. The respiratory exchange ratio data was significantly lowered (p less than 0.05) during workloads between 250 and 450 watts. No changes were seen in blood glucose or heart rates during the experiment. In conclusion, we feel that a 10 mg.kg-1 dose of caffeine is an ergogenic aid during incremental exercise when it is taken 3-4 hours prior to the exercise in fasting subjects who have diets low in caffeine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373575     DOI: 10.1055/s-2007-1024789

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  11 in total

Review 1.  Caffeine and endurance performance.

Authors:  M A Tarnopolsky
Journal:  Sports Med       Date:  1994-08       Impact factor: 11.136

2.  Effect of caffeine on oxidative stress during maximum incremental exercise.

Authors:  Guillermo J Olcina; Diego Muñoz; Rafael Timón; M Jesús Caballero; Juan I Maynar; Alfredo Córdova; Marcos Maynar
Journal:  J Sports Sci Med       Date:  2006-12-15       Impact factor: 2.988

Review 3.  Caffeine and exercise: metabolism, endurance and performance.

Authors:  T E Graham
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Effects of Energy Drinks on Economy and Cardiovascular Measures.

Authors:  Willard W Peveler; Gabe J Sanders; Cecile A Marczinski; Brady Holmer
Journal:  J Strength Cond Res       Date:  2017-04       Impact factor: 3.775

5.  Can I Have My Coffee and Drink It? A Systematic Review and Meta-analysis to Determine Whether Habitual Caffeine Consumption Affects the Ergogenic Effect of Caffeine.

Authors:  Arthur Carvalho; Felipe Miguel Marticorena; Beatriz Helena Grecco; Gabriel Barreto; Bryan Saunders
Journal:  Sports Med       Date:  2022-05-10       Impact factor: 11.928

Review 6.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  The effects of two levels of caffeine ingestion on excess postexercise oxygen consumption in untrained women.

Authors:  K Donelly; L McNaughton
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

Review 8.  Caffeine and exercise performance. An update.

Authors:  S L Dodd; R A Herb; S K Powers
Journal:  Sports Med       Date:  1993-01       Impact factor: 11.136

9.  Low doses of caffeine reduce heart rate during submaximal cycle ergometry.

Authors:  Steven R McClaran; Thomas J Wetter
Journal:  J Int Soc Sports Nutr       Date:  2007-10-09       Impact factor: 5.150

10.  Neuronal adenosine A2A receptors signal ergogenic effects of caffeine.

Authors:  Aderbal S Aguiar; Ana Elisa Speck; Paula M Canas; Rodrigo A Cunha
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.